{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:40:23Z","timestamp":1792122023450,"version":"4.4.0"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Hemoglobin A1c is central to diabetes diagnosis and monitoring, but its interpretation becomes clinically fragile when red-cell biology, hemoglobin composition, assay behavior, kidney failure, protein turnover, or glucose-data quality affects the assumptions behind the result. Existing reviews have described many causes of hemoglobin A1c-glycemia mismatch; the remaining practical problem is how clinicians and laboratories can choose a safer, decision-appropriate metric when the result is discordant with glucose data, symptoms, phenotype, or treatment response. This review synthesizes evidence from diabetes care, laboratory medicine, nephrology, hematology, and diabetes technology to propose a decision-oriented clinical-laboratory framework for selected high-risk settings: advanced chronic kidney disease and dialysis, anemia or altered red-cell turnover, and hemoglobin variants or hemoglobinopathies. The framework does not replace hemoglobin A1c with a single alternative marker. Instead, it asks which clinical decision is being made, whether hemoglobin A1c is biologically and analytically interpretable, whether comparator glucose data are adequate, and which adjunct metric is least likely to mislead in that scenario. Continuous glucose monitoring, structured self-monitoring, laboratory plasma glucose, glycated albumin, fructosamine, and selected secondary constructs are considered according to their decision value and failure modes. The proposed approach is an interpretive aid for clinician-laboratory communication, not a validated guideline, diagnostic algorithm, or therapeutic pathway.<\/jats:p>","DOI":"10.3389\/fendo.2026.1898713","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:26:41Z","timestamp":1788236801000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Glycemic assessment when hemoglobin A1c is unreliable: a clinical-laboratory framework for kidney disease, anemia, and hemoglobinopathies"],"prefix":"10.3389","volume":"17","author":[{"given":"Tianqiang","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Wenzhou TCM Hospital of Zhejiang Chinese Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Wenzhou TCM Hospital of Zhejiang Chinese Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpin","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Wenzhou TCM Hospital of Zhejiang Chinese Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S007","article-title":"7. Diabetes technology: Standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0036","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"46","author":"Sacks","year":"2023","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0545","article-title":"Translating the A1C assay into estimated average glucose values","volume":"31","author":"Nathan","year":"2008","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2026.113216","article-title":"Navigating the discordance: a comprehensive review of HbA1c-glycemia mismatch in clinical practice","volume":"235","author":"Sureshkumar","year":"2026","journal-title":"Diabetes Res Clin Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70023","article-title":"Managing discordance between HbA1c and glucose management indicator","volume":"42","author":"Lenters-Westra","year":"2025","journal-title":"Diabetes Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3599-3","article-title":"The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review","volume":"58","author":"English","year":"2015","journal-title":"Diabetologia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cca.2022.11.031","article-title":"Interference of hemoglobin variants in HbA1c quantification","volume":"539","author":"Yadav","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/dci24-0081","article-title":"Glycemic management and individualized diabetes care in dialysis-dependent kidney failure","volume":"48","author":"Klein","year":"2025","journal-title":"Diabetes Care"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1581","article-title":"Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.024802","article-title":"IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study","volume":"50","author":"Hoelzel","year":"2004","journal-title":"Clin Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaf059","article-title":"Challenges in Hb A1c point-of-care testing: Only 5 of 19 Hb A1c point-of-care devices meet IFCC and NGSP certification criteria on independent evaluation","volume":"71","author":"Lenters-Westra","year":"2025","journal-title":"Clin Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0040","article-title":"Point-of-care HbA1c in clinical practice: Caveats and considerations for optimal use","volume":"47","author":"Sacks","year":"2024","journal-title":"Diabetes Care"},{"key":"B15","first-page":"195","article-title":"Comparative analysis of HbA1c estimation using immunoturbidimetry and high-pressure liquid chromatography methods in non-dialysis chronic kidney disease patients","volume":"35","author":"Dhingra","year":"2024","journal-title":"EJIFCC"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S006","article-title":"6. Glycemic goals, hypoglycemia, and hyperglycemic crises: Standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S011","article-title":"11. Chronic kidney disease and risk management: Standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1159\/000511614","article-title":"The use of HbA1c, glycated albumin and continuous glucose monitoring to assess glucose control in the chronic kidney disease population including dialysis","volume":"145","author":"Bomholt","year":"2021","journal-title":"Nephron"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-2952","article-title":"Accuracy, variability, and bias of glycemic biomarkers in patients treated with maintenance dialysis","volume":"49","author":"Zelnick","year":"2026","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000663","article-title":"Effect of carbamylation and anemia on the association between glycated albumin and kidney outcomes in diabetic kidney disease","volume":"20","author":"Tang","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/20420188241252546","article-title":"HbA1c overestimates the glucose management indicator: a pilot study in patients with diabetes, chronic kidney disease not on dialysis, and anemia using isCGM","volume":"15","author":"G\u00f3mez Medina","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1681\/ASN.2006070772","article-title":"Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection","volume":"18","author":"Inaba","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.25","article-title":"Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis","volume":"73","author":"Peacock","year":"2008","journal-title":"Kidney Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3390\/biomedicines14040845","article-title":"Effect of roxadustat and erythropoietin on glycated hemoglobin of non-dialysis type 2 diabetic nephropathy anemia patients","volume":"14","author":"Xiang","year":"2026","journal-title":"Biomedicines"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/19322968241292041","article-title":"Consensus report on the use of continuous glucose monitoring in chronic kidney disease and diabetes","volume":"19","author":"Rhee","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.13618","article-title":"Assessment of the accuracy of an intermittent-scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study","volume":"25","author":"Toyoda","year":"2021","journal-title":"Ther Apher Dial"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/19322968251318758","article-title":"Accuracy of continuous glucose monitoring in people with type 1 diabetes receiving hemodialysis in hospital","volume":"19","author":"Wang","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0575","article-title":"Accuracy of the Dexcom G7 continuous glucose monitoring sensors in people with diabetes undergoing hemodialysis (ALPHA-2 study)","volume":"27","author":"Avari","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-0635","article-title":"Accuracy of continuous glucose monitoring in hemodialysis patients with diabetes","volume":"47","author":"Narasaki","year":"2024","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000519050","article-title":"The accuracy of hemoglobin A1c and fructosamine evaluated by long-term continuous glucose monitoring in patients with type 2 diabetes undergoing hemodialysis","volume":"51","author":"Bomholt","year":"2022","journal-title":"Blood Purif"},{"key":"B31","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/medicina57070712","article-title":"Biomarkers of glyco-metabolic control in hemodialysis patients: Glycated hemoglobin vs. glycated albumin","volume":"57","author":"Martino","year":"2021","journal-title":"Med (Kaunas)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13286","article-title":"Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis","volume":"11","author":"Ushigome","year":"2020","journal-title":"J Diabetes Investig"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107680","article-title":"Comparison of accuracy between flash glucose monitoring and continuous glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"34","author":"Matoba","year":"2020","journal-title":"J Diabetes Complications"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0145","article-title":"Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis","volume":"26","author":"Galindo","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2337\/dsi24-0015","article-title":"Diabetes and glucose management in people on hemodialysis","volume":"38","author":"Agarwal","year":"2025","journal-title":"Diabetes Spectr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0349","article-title":"Impact of body composition and anemia on accuracy of a real-time continuous glucose monitor in diabetes patients on continuous ambulatory peritoneal dialysis","volume":"26","author":"Ling","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12988","article-title":"Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia","volume":"33","author":"Oei","year":"2016","journal-title":"Diabetes Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/ijms17050619","article-title":"Glycated albumin versus glycated hemoglobin as a glycemic indicator in diabetic patients on peritoneal dialysis","volume":"17","author":"Kobayashi","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1159\/000519493","article-title":"Hemoglobin A1c and fructosamine evaluated in patients with type 2 diabetes receiving peritoneal dialysis using long-term continuous glucose monitoring","volume":"146","author":"Bomholt","year":"2022","journal-title":"Nephron"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-1276","article-title":"Assessment of glycemic control by continuous glucose monitoring, hemoglobin A1c, fructosamine, and glycated albumin in patients with end-stage kidney disease and burnt-out diabetes","volume":"47","author":"Kaminski","year":"2024","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2024.02.006","article-title":"Glycated albumin and adverse clinical outcomes in patients with CKD: a prospective cohort study","volume":"84","author":"Tang","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814567227","article-title":"Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes","volume":"9","author":"Danese","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cca.2014.03.001","article-title":"Glycated albumin; clinical usefulness","volume":"433","author":"Koga","year":"2014","journal-title":"Clin Chim Acta"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac297","article-title":"Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new association","volume":"38","author":"Hoshino","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231191544","article-title":"Age and red blood cell parameters mainly explain the differences between HbA1c and glycemic management indicator among patients with type 1 diabetes using intermittent continuous glucose monitoring","volume":"18","author":"Azcoitia","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2016.10.003","article-title":"Effect of iron deficiency anemia and iron supplementation on HbA1c levels - Implications for diagnosis of prediabetes and diabetes mellitus in Asian Indians","volume":"468","author":"Madhu","year":"2017","journal-title":"Clin Chim Acta"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-020-01661-6","article-title":"HbA1c level decreases in iron deficiency anemia","volume":"133","author":"\u00c7etinkaya Altunta\u015f","year":"2021","journal-title":"Wien Klin Wochenschr"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1757589","article-title":"Effect of iron deficiency anemia on glycated albumin levels: a comparative study in nondiabetic subjects with iron deficiency anemia","volume":"15","author":"Jyothsna","year":"2023","journal-title":"J Lab Physicians"},{"key":"B49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12902-023-01280-y","article-title":"The effect of different types of anemia on HbA1c levels in non-diabetics","volume":"23","author":"Alzahrani","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2022.01.002","article-title":"Relationship between glycosylated hemoglobin and iron deficiency anemia: a common but overlooked problem","volume":"16","author":"Ayd\u0131n","year":"2022","journal-title":"Prim Care Diabetes"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11479","article-title":"Glycated haemoglobin (HbA1c) variations in nondiabetics with nutritional anemia","volume":"12","author":"Pilla","year":"2020","journal-title":"Cureus"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2022.76259","article-title":"Relationship between glycosylated hemoglobin and vitamin B12 deficiency anemia","volume":"9","author":"Aydin","year":"2022","journal-title":"North Clin Istanb"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0917","article-title":"The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease","volume":"33","author":"Ng","year":"2010","journal-title":"Diabetes Care"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.ijem_265_25","article-title":"The utility of HbA1c and fructosamine in evaluating the glucose tolerance in adult patients with transfusion-dependent beta-thalassemia","volume":"29","author":"Arjunan","year":"2025","journal-title":"Indian J Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112076","article-title":"Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study","volume":"222","author":"Zanfardino","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.91386","article-title":"Low hemoglobin A1c (HbA1c) revealing hemolytic anemia in a growth hormone-treated child: A case report","volume":"17","author":"Ito","year":"2025","journal-title":"Cureus"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0334634","article-title":"HbA1c underperforms in identifying abnormal glucose tolerance in the presence of G6PD deficiency: Insight from the Africans in America study","volume":"21","author":"Bentley","year":"2026","journal-title":"PloS One"},{"key":"B58","doi-asserted-by":"publisher","first-page":"BSR20192300","DOI":"10.1042\/BSR20192300","article-title":"Comparative study on hemoglobin A1c, glycated albumin and glycosylated serum protein in aplastic anemia patients with type 2 diabetes mellitus","volume":"40","author":"Suo","year":"2020","journal-title":"Biosci Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2013.01.004","article-title":"Interference of the most frequent haemoglobin variants on quantification of HbA1c: Comparison between the LC-MS (IFCC reference method) and three routinely used methods","volume":"39","author":"Jaisson","year":"2013","journal-title":"Diabetes Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmae034","article-title":"Interference of hemoglobin variants with HbA1c measurements by six commonly used HbA1c methods","volume":"55","author":"Li","year":"2024","journal-title":"Lab Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2024-0186","article-title":"Evaluation of effects from hemoglobin variants on HbA1c measurements by different methods","volume":"62","author":"Song","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/00365513.2022.2155990","article-title":"Evaluation of interference from 16 hemoglobin variants on hemoglobin A1c measurement by five methods","volume":"83","author":"Yang","year":"2023","journal-title":"Scand J Clin Lab Invest"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.105572","article-title":"Major discordance in hemoglobin A1c measurement in sickle cell trait: Effect of analytical methods","volume":"18","author":"Rakotonjafiniarivo","year":"2026","journal-title":"Cureus"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77374","article-title":"The performance of three systems of glycated hemoglobin measurements among patients with sickle cell trait in Basrah, Iraq","volume":"17","author":"Al-Naseri","year":"2025","journal-title":"Cureus"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2024.48.10.41679","article-title":"Impact of haemoglobin variants on the diagnostic sensitivity of glycated haemoglobin (HbA1c) assay methodologies in sub-Saharan Africa: A laboratory-based method validation study","volume":"48","author":"Balungi","year":"2024","journal-title":"Pan Afr Med J"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2024.240042R1","article-title":"Screening and diagnosis of type 2 diabetes in sickle cell disease","volume":"37","author":"Carrithers","year":"2024","journal-title":"J Am Board Fam Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfac135","article-title":"Analytical and clinical significance of rare hemoglobin variants during HbA1c monitoring in patients with diabetes mellitus: Two cases of hemoglobin G-Ferrara and hemoglobin G-Copenhagen in diabetic patients with sickle cell trait","volume":"8","author":"Karimi","year":"2023","journal-title":"J Appl Lab Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.101623","article-title":"Diagnostic limitations of hemoglobin A1c in the setting of compound hemoglobinopathy: A case report of sickle cell disease, alpha thalassemia, and occult diabetes","volume":"18","author":"Toperzer","year":"2026","journal-title":"Cureus"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2026.2665490","article-title":"First report of a rare hemoglobin variant in the Chinese population: Clinical and hematological characteristics of Hb Norton [HBA2:c.217C>G] and its impact on HbA1c testing: A case report","volume":"31","author":"Shang","year":"2026","journal-title":"Hematology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1080\/03630269.2025.2524437","article-title":"A rare hemoglobin variant detected for the first time in T\u00fcrkiye (Hb Iraq-Halabja): Evaluation of the effect of variant hemoglobins on HbA1c methods","volume":"49","author":"Balc\u0131","year":"2025","journal-title":"Hemoglobin"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2024.0182","article-title":"Ability of the capillary electrophoresis-based HbA1c assay to detect rare hemoglobin variants","volume":"45","author":"Olivieri","year":"2025","journal-title":"Ann Lab Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244782","article-title":"Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study","volume":"15","author":"Kweka","year":"2020","journal-title":"PloS One"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1515\/almed-2024-0037","article-title":"False HbA1c value due to a rare variant of hemoglobin Petie Salpetriere coinherited with alpha thalassemia","volume":"5","author":"Lepe Balsalobre","year":"2024","journal-title":"Adv Lab Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/medsci9020043","article-title":"Misleading HbA1c measurement in diabetic patients with hemoglobin variants","volume":"9","author":"Mitchai","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-020-00936-z","article-title":"Incidental detection of hemoglobin variants during evaluation of HbA1c","volume":"37","author":"Kulkarni","year":"2022","journal-title":"Indian J Clin Biochem"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-014-0548-3","article-title":"Beyond HbA1c and glucose: The role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management","volume":"14","author":"Parrinello","year":"2014","journal-title":"Curr Diabetes Rep"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01572-z","article-title":"Associations between HbA1c and glucose time in range using continuous glucose monitoring in type 1 diabetes: Cross-sectional population-based study","volume":"15","author":"Eliasson","year":"2024","journal-title":"Diabetes Ther"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K10E-138","article-title":"Clinical impact of glycated albumin as another glycemic control marker","volume":"57","author":"Koga","year":"2010","journal-title":"Endocr J"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.015415","article-title":"Fructosamine and glycated albumin and the risk of cardiovascular outcomes and death","volume":"132","author":"Selvin","year":"2015","journal-title":"Circulation"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad298","article-title":"Glycated albumin correlates with time-in-range better than HbA1c or fructosamine","volume":"108","author":"Desouza","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14685","article-title":"HbA1c combined with glycated albumin or 1,5-anhydroglucitol improves the efficiency of diabetes screening in a Chinese population","volume":"39","author":"Qian","year":"2022","journal-title":"Diabetes Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2011.00764.x","article-title":"The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring","volume":"12","author":"Beck","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70072","article-title":"Association of the glycated albumin-to-glycated haemoglobin ratio with mortality in type 2 diabetes: A retrospective cohort analysis","volume":"8","author":"Gohda","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S297730","article-title":"Association of glycated albumin\/glycosylated hemoglobin ratio with blood glucose fluctuation and long-term blood glucose control in patients with type 2 diabetes mellitus","volume":"14","author":"Wang","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2023.01.001","article-title":"Correlation between hemoglobin glycation index measured by continuous glucose monitoring with complications in type 1 diabetes","volume":"29","author":"Ibarra-Salce","year":"2023","journal-title":"Endocr Pract"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1177\/0004563216675646","article-title":"Alcohol consumption reduces HbA1c and glycated albumin concentrations but not 1,5-anhydroglucitol","volume":"54","author":"Inada","year":"2017","journal-title":"Ann Clin Biochem"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/576306","article-title":"Glycated albumin levels in patients with type 2 diabetes increase relative to HbA1c with time","volume":"2015","author":"Yoon","year":"2015","journal-title":"BioMed Res Int"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112325","article-title":"Associations of time in tight range, time in range, and glycated hemoglobin with albuminuria in type 1 diabetes: A cross-sectional study","volume":"226","author":"Kim","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.08.012","article-title":"Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"102","author":"de Boer","year":"2022","journal-title":"Kidney Int"},{"key":"B90","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12882-024-03763-z","article-title":"Efficacy of continuous glucose monitoring in people living with diabetes and end stage kidney disease on dialysis: A systematic review","volume":"25","author":"Zhang","year":"2024","journal-title":"BMC Nephrol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1898713\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:26:42Z","timestamp":1788236802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1898713\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":90,"alternative-id":["10.3389\/fendo.2026.1898713"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1898713","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"1898713"}}